Crescent Biopharma, Inc. Common Stock (CBIO) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for CBIO. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 79 institutions reported holding CBIO, with 29.6 million shares worth $532.6 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| FMR | 4,133,514 | $74M | UNCHANGED |
| Bvf Inc/IL | 2,748,763 | $49M | UNCHANGED |
| Fairmount Funds Management | 2,747,866 | $49M | UNCHANGED |
| VR Adviser | 2,133,576 | $38M | UNCHANGED |
| Logos Global Management | 1,900,000 | $34M | INCREASED |
Full institutional holdings, insider history, and congressional trades for Crescent Biopharma, Inc. Common Stock on SentiSense.